Intrinsic differences between FVIIIa mimetic bispecific antibodies and FVIII prevent assignment of FVIII-equivalence

Leksa, NC; Aleman, MM; Goodman, AG; Rabinovich, D; Peters, R; Salas, J

Salas, J (reprint author), Sanofi, Waltham, MA 02451 USA.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019; 17 (7): 1044

Abstract

Essentials Non-factor VIII (FVIII) therapies for hemophilia A, such as bispecific antibodies (bsAbs), are in development. Bispecific antibodies are in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索